Clinical Trial Update: Individually Tailored Prophylaxis in Patients With Severe Hemophilia A [NA]

View source ↗

Summary

The clinical trial 'Individually Tailored Prophylaxis in Patients With Severe Hemophilia A' has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemophilia

Snippet

Sponsor: Hospices Civils de Lyon | Conditions: Hemophilia A | NA | Status: TERMINATED